Optivite® PMT is the first multivitamin - multimineral supplement formulated for use by women with Premenstrual tension syndromes (PMTS). Available to PMTS sufferers over the past 20 years, Optivite® underwent several clinical studies published in peer-reviewed medical journals: 3 open trials and 2 double blind placebo-controlled studies.
A 50% reduction of PMTS complaints has been observed in those studies following 1 to 3 months on this supplement.
When 313 PMTS sufferers were followed for up to 5 years on this program, an interesting observation was that the number of tablets of Optivite required to maintain the improvement in PMTS complaints decreased over time: 5.2 + 0.36 tablets between 2 and 6 months: 4.8 + 0.6 tablets between 7 and 12 months: 4.3 + 0.48 tablets between 13 and 24 months and 3.2 + 0.34 tablets over 24 months (1).
With over 100,000 women on this program during the first 5 years of availability of Optivite®, not a single documented case of Vitamin A toxicity and peripheral neuropathy due to Vitamin B-6 has been reported (1).
Optivite® is recommended as part of a total dietary program to obtain best results.

Suggested Use:
Two to six tablets daily as part of a dietary program or as directed by a physician.

WARNING:

• Do not use if outer seal is broken
• If pregnant or lactating, consult physician before use
• Do not exceed six tablets per day
• Read brochure inside bottle before use
• If taking any prescription drugs, consult physician before use
• Do not use for pernicious anemia, or if you have hemochromatosis or hemosiderosis

Click here to download a brochure

Accidental over dose of iron-containing products is a leading causes of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.